3R-Tau Protein

3R-Tau Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | 3-Repeat Tau Isoform |
| Gene | MAPT |
| UniProt ID | P10636-8 |
| PDB Structures | 3QL4, 4NP8 |
| Molecular Weight | 45-68 kDa |
| Subcellular Localization | Axons, neuronal soma |
| Protein Family | MAPT family, microtubule-associated proteins |

</div>

Overview

3R-Tau refers to tau protein isoforms containing three microtubule-binding repeat domains, generated by alternative splicing of the MAPT gene[@goedert1992]. The tau protein is encoded by the MAPT gene on chromosome 17q21, and alternative splicing of exon 10 determines whether the protein contains three (3R) or four (4R) microtubule-binding repeats. This difference in isoform composition has significant implications for both normal neuronal function and the pathogenesis of various neurodegenerative diseases known as tauopathies.

Structure

Isoform Composition

3R-Tau isoforms are generated by exclusion of exon 10 during mRNA splicing:

• Repeat domain structure: Contains R1, R3, and R4 repeats (lacks R2)
• Microtubule-binding regions: Three hexapeptide motifs (^275KVQIINKK^280, ^306VQIVYKPVDLSKVTSKC^322)
• N-terminal inserts: Can have 0, 1, or 2 N-terminal inserts (0N, 1N, 2N isoforms)
• Total length: 352-381 amino acids depending on N-terminal splicing

Structural Features

...

3R-Tau Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | 3-Repeat Tau Isoform |
| Gene | MAPT |
| UniProt ID | P10636-8 |
| PDB Structures | 3QL4, 4NP8 |
| Molecular Weight | 45-68 kDa |
| Subcellular Localization | Axons, neuronal soma |
| Protein Family | MAPT family, microtubule-associated proteins |

</div>

Overview

3R-Tau refers to tau protein isoforms containing three microtubule-binding repeat domains, generated by alternative splicing of the MAPT gene[@goedert1992]. The tau protein is encoded by the MAPT gene on chromosome 17q21, and alternative splicing of exon 10 determines whether the protein contains three (3R) or four (4R) microtubule-binding repeats. This difference in isoform composition has significant implications for both normal neuronal function and the pathogenesis of various neurodegenerative diseases known as tauopathies.

Structure

Isoform Composition

3R-Tau isoforms are generated by exclusion of exon 10 during mRNA splicing:

• Repeat domain structure: Contains R1, R3, and R4 repeats (lacks R2)
• Microtubule-binding regions: Three hexapeptide motifs (^275KVQIINKK^280, ^306VQIVYKPVDLSKVTSKC^322)
• N-terminal inserts: Can have 0, 1, or 2 N-terminal inserts (0N, 1N, 2N isoforms)
• Total length: 352-381 amino acids depending on N-terminal splicing

Structural Features

• Proline-rich domain: Projecting N-terminal region that modulates interactions
• Repeat domain: Core microtubule-binding region
• C-terminal region: Involved in filament formation
• Phosphorylation sites: Multiple serine, threonine, and tyrosine residues

Normal Function

Microtubule Dynamics

3R-Tau isoforms play essential roles in neuronal cells[@ballatore2007]:

• Microtubule assembly: Promotes tubulin polymerization into microtubules
• Axonal transport: Supports bidirectional transport via motor proteins (kinesins, dyneins)
• Cytoskeletal stability: Maintains axonal architecture
• Synaptic function: Regulates synaptic vesicle trafficking

Developmental Regulation

• Fetal expression: High levels in developing brain
• Adult expression: Reduced but maintained in specific neuronal populations
• Isoform switching: Transition from 3R to 4R during development

Role in Disease

Alzheimer's Disease (AD)

3R-Tau is a major component of neurofibrillary tangles in AD[@goedert1992][@spillantini2013]:

• Mixed pathology: AD brains contain approximately equal 3R and 4R tau
• NFT formation: Both 3R and 4R tau aggregate into paired helical filaments
• Braak staging: Tau pathology spreads in a predictable pattern
• Correlation with cognition: NFT burden correlates with cognitive decline

Pick's Disease

3R-Tau is predominant in Pick's disease:

• Pick bodies: Spherical tau inclusions composed primarily of 3R tau
• 3R-predominant: >90% of tau in Pick bodies is 3R isoform
• Behavioral variant FTD: Presents as behavioral disinhibition
• Sparing of other brain regions: Relative preservation vs. AD

Other Tauopathies

• Chronic traumatic encephalopathy (CTE): Mixed 3R/4R pathology
• Down syndrome with AD: Early 3R-tau pathology
• Senile degeneration: Variable 3R/4R ratios

3R vs. 4R Tau Differences

| Feature | 3R-Tau | 4R-Tau |
|---------|--------|--------|
| Repeat domains | R1, R3, R4 | R1-R4 |
| Microtubule affinity | Lower | Higher |
| Aggregation propensity | Similar | Similar |
| Developmental expression | Early | Later |
| Adult brain ratio | ~50% | ~50% (AD) |

Therapeutic Implications

Current Approaches

• Tau aggregation inhibitors: Target both 3R and 4R aggregation
• Anti-tau immunotherapies: Antibodies targeting phosphorylated tau
• Kinase inhibitors: Block tau-phosphorylating enzymes
• Splice-modulating therapies: Target exon 10 splicing

3R-Specific Considerations

• Exon 10 splicing modulators: ASOs targeting splicing regulatory elements
• Isoform-specific antibodies: Potential for isoform-targeted therapy
• Biomarker development: 3R-tau-specific CSF markers

Key Publications

[Goedert, M. et al. (1992) Tau protein isoforms in neurodegeneration](https://doi.org/10.1016/0092-8674(92)90513-M)

[Spillantini, M.G. & Goedert, M. (2013) Tau pathology in neurodegenerative diseases](https://doi.org/10.1093/brain/awt079)

[Sergeant, N. et al. (2008) 3R-tau in Pick's disease](https://doi.org/10.1007/s00401-008-0377-z)

Cross-References

• [MAPT Gene](/genes/mapt) — Gene encoding tau](/genes)
• [Tau Protein](/proteins/tau) — Full-length tau](/proteins)
• [4R-Tau Protein](/proteins/4r-tau) — Four-repeat isoform](/proteins)
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease
• [Pick's Disease](/diseases/picks-disease) — 3R-predominant tauopathy

See Also

• [Tau Protein](/proteins/tau) — Related tau kinase substrate in AD](/proteins)
• [Amyloid-Beta](/proteins/amyloid-beta) — Related APP cleavage product](/proteins)
• [GSK3B](/genes/gsk3b) — Major kinase in neurodegeneration](/genes)
• [CDK5](/genes/cdk5) — Another tau kinase](/genes)
• [BACE1](/genes/bace1) — Beta-secretase in amyloidogenesis

External Links

• [UniProt](https://www.uniprot.org/) - Protein sequence and functional data
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [PDB](https://www.rcsb.org/) - Protein structure data
• [Allen Human Brain Atlas](https://brain-map.org/) - Gene expression data for MAPT in human brain

References

[Goedert, M. et al., (1992). Tau protein isoforms in neurodegeneration. Nature, 360(6405), 674-677 (1992)](https://doi.org/10.1016/0092-8674(92)

[Ballatore, C. et al., (2007). Tau-mediated neurodegeneration. Nature Reviews Neuroscience, 8(9), 663-672 (2007)](https://doi.org/10.1038/nrm2244)

[Unknown, Spillantini, M.G. & Goedert, M. (2013). Tau pathology in neurodegenerative diseases. Brain, 136(Pt 9), 2691-2700 (2013)](https://doi.org/10.1093/brain/awt079)